1,292
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Envisioning the development of a CRISPR-Cas mediated base editing strategy for a patient with a novel pathogenic CRB1 single nucleotide variant

, , , , &
Pages 661-670 | Received 22 Dec 2021, Accepted 30 Apr 2022, Published online: 10 May 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.